Radiochemistry
A special issue of Pharmaceuticals (ISSN 1424-8247).
Deadline for manuscript submissions: closed (30 May 2012) | Viewed by 17521
Special Issue Editor
Interests: radiochemistry; radiopharmacy; GMP-production; drug degradation; receptor kinetics; analytical methods; chelation; medicinal chemistry
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Radiochemistry is the chemistry of radioactive materials. The research interest in this field of chemistry has experienced a big growth during the last decades, driven by a demand of being able to visualize biological processes in the human body. This special issue of Pharmaceuticals, dedicated to radiochemistry, calls for both fundamental and applied contributions in this field of growing academic and industrial interests. Special attention will be paid to paper which has a high degree of novelty, which can contribute to making everyday life easier for radio chemists, which can have a (potential) diagnostic impact or/and which contribute to the understanding of biological processes in vivo.
Dr. Svend Borup Jensen
Guest Editor
Keywords
- incorporation of radioactive isotopes into biological interesting compounds
- radioactive labeled compounds metabolic pathway
- synthesis of precursor and reference materials
- quality control of radiopharmaceuticals
- purification technics
- non-commercial equipment
- PET molecules
- SPEC molecules
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
Related Special Issues
- Emerging Theranostic Tracers in the Context of Radiopharmaceutical Drug Development in Pharmaceuticals (11 articles)
- Radiopharmaceutical Chemistry between Imaging and Radioendotherapy in Pharmaceuticals (12 articles)
- Preparation of Radiopharmaceuticals and Their Use in Drug Development in Pharmaceuticals (3 articles)
- New Challenges in Radiochemistry in Pharmaceuticals (3 articles)
- Targets, Tracers and Translation – Novel Radiopharmaceuticals Boost Nuclear Medicine in Pharmaceuticals (16 articles)
- The Future Direction of Radiopharmaceutical Development for Cancer Theranostics in Pharmaceuticals (9 articles)
- Next Generation of MRI Agents in Pharmaceuticals (9 articles)
- Radiopharmaceuticals for Relapsed or Refractory Ovarian Cancers in Pharmaceuticals (1 article)
- Radiochemistry in Molecules (4 articles)
- Forward Thinking towards Theranostic (Radio)ligands Targeting the Tumor Microenvironment (TME) in Pharmaceuticals (6 articles)
